Pulmonary Hypertension Associated with Respiratory Disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pulmonary hypertension is a common complication of many chronic respiratory diseases. The mechanisms contributing to the development of pulmonary hypertension in this context are multiple and go beyond chronic hypoxic vasoconstriction. Outcomes are universally worsened when pulmonary hypertension complicates chronic respiratory disease. Treatment strategies target the underlying disease, as pulmonary vasodilator therapy has proven largely ineffective in trials to date. This chapter summarizes current understanding of the epidemiology, pathophysiology, and treatment of pulmonary hypertension as it relates to a spectrum of chronic respiratory diseases.

Original languageEnglish (US)
Title of host publicationPanVascular Medicine, Second Edition
PublisherSpringer Berlin Heidelberg
Pages4211-4231
Number of pages21
ISBN (Print)9783642370786, 9783642370779
DOIs
StatePublished - Jan 1 2015

Fingerprint

Pulmonary diseases
Pulmonary Hypertension
Chronic Disease
Epidemiology
Vasodilator Agents
Vasoconstriction
Lung Diseases
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kolb, T. M., & Hassoun, P. M. (2015). Pulmonary Hypertension Associated with Respiratory Disease. In PanVascular Medicine, Second Edition (pp. 4211-4231). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-37078-6_163

Pulmonary Hypertension Associated with Respiratory Disease. / Kolb, Todd Matthew; Hassoun, Paul M.

PanVascular Medicine, Second Edition. Springer Berlin Heidelberg, 2015. p. 4211-4231.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kolb, TM & Hassoun, PM 2015, Pulmonary Hypertension Associated with Respiratory Disease. in PanVascular Medicine, Second Edition. Springer Berlin Heidelberg, pp. 4211-4231. https://doi.org/10.1007/978-3-642-37078-6_163
Kolb TM, Hassoun PM. Pulmonary Hypertension Associated with Respiratory Disease. In PanVascular Medicine, Second Edition. Springer Berlin Heidelberg. 2015. p. 4211-4231 https://doi.org/10.1007/978-3-642-37078-6_163
Kolb, Todd Matthew ; Hassoun, Paul M. / Pulmonary Hypertension Associated with Respiratory Disease. PanVascular Medicine, Second Edition. Springer Berlin Heidelberg, 2015. pp. 4211-4231
@inbook{a8ab390f8e884242af6de218dd2db4e1,
title = "Pulmonary Hypertension Associated with Respiratory Disease",
abstract = "Pulmonary hypertension is a common complication of many chronic respiratory diseases. The mechanisms contributing to the development of pulmonary hypertension in this context are multiple and go beyond chronic hypoxic vasoconstriction. Outcomes are universally worsened when pulmonary hypertension complicates chronic respiratory disease. Treatment strategies target the underlying disease, as pulmonary vasodilator therapy has proven largely ineffective in trials to date. This chapter summarizes current understanding of the epidemiology, pathophysiology, and treatment of pulmonary hypertension as it relates to a spectrum of chronic respiratory diseases.",
author = "Kolb, {Todd Matthew} and Hassoun, {Paul M}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-642-37078-6_163",
language = "English (US)",
isbn = "9783642370786",
pages = "4211--4231",
booktitle = "PanVascular Medicine, Second Edition",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Pulmonary Hypertension Associated with Respiratory Disease

AU - Kolb, Todd Matthew

AU - Hassoun, Paul M

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pulmonary hypertension is a common complication of many chronic respiratory diseases. The mechanisms contributing to the development of pulmonary hypertension in this context are multiple and go beyond chronic hypoxic vasoconstriction. Outcomes are universally worsened when pulmonary hypertension complicates chronic respiratory disease. Treatment strategies target the underlying disease, as pulmonary vasodilator therapy has proven largely ineffective in trials to date. This chapter summarizes current understanding of the epidemiology, pathophysiology, and treatment of pulmonary hypertension as it relates to a spectrum of chronic respiratory diseases.

AB - Pulmonary hypertension is a common complication of many chronic respiratory diseases. The mechanisms contributing to the development of pulmonary hypertension in this context are multiple and go beyond chronic hypoxic vasoconstriction. Outcomes are universally worsened when pulmonary hypertension complicates chronic respiratory disease. Treatment strategies target the underlying disease, as pulmonary vasodilator therapy has proven largely ineffective in trials to date. This chapter summarizes current understanding of the epidemiology, pathophysiology, and treatment of pulmonary hypertension as it relates to a spectrum of chronic respiratory diseases.

UR - http://www.scopus.com/inward/record.url?scp=84957016498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957016498&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-37078-6_163

DO - 10.1007/978-3-642-37078-6_163

M3 - Chapter

AN - SCOPUS:84957016498

SN - 9783642370786

SN - 9783642370779

SP - 4211

EP - 4231

BT - PanVascular Medicine, Second Edition

PB - Springer Berlin Heidelberg

ER -